|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
Netherlands Trial Register |
|
Last refreshed on:
|
28 April 2013 |
|
Main ID: |
NTR747 |
|
Date of registration:
|
03/08/2006 |
|
Primary sponsor: |
|
|
Public title:
|
The effectiveness of supportgroups for people suffering from psychosis: a randomized controlled trial.
|
|
Scientific title:
|
The effectiveness of supportgroups for people suffering from psychosis: a randomized controlled trial. - N/A |
|
Date of first enrolment:
|
1/2/2003 |
|
Target sample size:
|
106 |
|
Recruitment status: |
complete |
|
URL:
|
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=747 |
|
Study type:
|
intervention |
|
Study design:
|
Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: 2 or more arms, randomized
|
|
|
Countries of recruitment
|
|
The Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
S.
Castelein |
|
Address:
|
University Medical Center Groningen (UMCG), department of psychiatry
RGOc, room 5.29
P.O Box 30.001
9700 RB
Groningen
The Netherlands |
|
Telephone:
|
+31(0)50 3611956 |
|
Email:
|
s.castelein@psy.umcg.nl |
|
Affiliation:
|
|
|
|
Name:
|
S.
Castelein |
|
Address:
|
University Medical Center Groningen (UMCG), department of psychiatry
RGOc, room 5.29
P.O Box 30.001
9700 RB
Groningen
The Netherlands |
|
Telephone:
|
+31(0)50 3611956 |
|
Email:
|
s.castelein@psy.umcg.nl |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Suffered from one or more psychotic episodes;
2. Outpatient;
3. 18 years or older.
Exclusion criteria: 1. Drug- or alcohol misuse;
2. Suffering from psychotic symptoms that influence the group process.
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
Schizophrenia, Psychosis
|
|
Intervention(s)
|
|
The peer support group involved 16 sessions of 1 ½ hours. The waiting-list control group received treatment as usual (TAU). The trial took place over 8 months. The groups ? with approximately 10 patients - were minimal guided by a nurse. Nurses were trained in the methodology which was especially developed for people with schizophrenia. The nurse was present at the start from the start and did offer structure, but did not interfere with the group process.
|
|
Primary Outcome(s)
|
|
Quality of Life: WHO Qol Bref.
|
|
Secondary Outcome(s)
|
1. Social support;
2. Social network;
3. Self-efficacy;
4. Self esteem;
5. Psychopathology.
|
|
Secondary ID(s)
|
|
ISRCTN02457313
|
|
N/A
|
|
Source(s) of Monetary Support
|
|
ZON-MW, The Netherlands Organization for Health Research and Development
|
|